English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/49845
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Characterization of murine S-endoglin isoform and its effects on tumor development

AuthorsPérez-Gómez, Eduardo ; Eleno, Nélida; López-Novoa, José M.; Ramírez, José Ramón; Velasco, Beatriz; Letarte, Michelle; Bernabéu, Carmelo ; Quintanilla, Miguel
Keywordsendoglin
TGF
endothelial cells
angiogenesis
carcinogenesis
Issue Date23-Jun-2005
PublisherNature Publishing Group
CitationOncogene 24,4450-4461(2005)
AbstractEndoglin is a transmembrane glycoprotein that acts as an auxiliary receptor for transforming growth factor- (TGF-) and modulates cellular responses to this pleiotropic cytokine. Endoglin is strongly expressed in endothelial cells, where it appears to exert a crucial role in vascular development and angiogenesis. Two endoglin isoforms (L and S), differing in their cytoplasmic domains, have been previously characterized in human tissues. We now demonstrate the existence of similar L- and S-endoglin variants in murine tissues with 47 and 35 amino acids, respectively, in their cytoplasmic tail. RT–PCR analysis showed that L is the predominant endoglin isoform expressed in mouse tissues, although S-endoglin mRNA is significantly expressed in liver and lung, as well as in endothelial cell lines. Furthermore, a protein of size equivalent to recombinant S-endoglin expressed in mammalian cells was detected in mouse endothelial cells by Western blot analysis. L- and S-endoglin isoforms can form disulfide-linked heterodimers, as demonstrated by cotransfection of L- and S-endoglin constructs. To address the role of S-endoglin in vivo, an S-Eng+ transgenic mouse model that targets S-endoglin expression to the endothelium was generated. The lethal phenotype of endoglin-null (Eng-/-) mice was not rescued by breeding S-Eng+ transgenic mice into the endoglin-null background. S-Eng+ mice exhibited reduced tumor growth and neovascularization after transplantation of Lewis lung carcinoma cells. In addition, S-Eng+ mice showed a drastic inhibition of benign papilloma formation when subjected to two-stage chemical skin carcinogenesis. These results point to S-endoglin as an antiangiogenic molecule, in contrast to L-endoglin which is proangiogenic
Description12 páginas, 6 figuras, 2 tablas -- PAGS nros. 4450-4461
Publisher version (URL)http://dx.doi.org/ 10.1038/sj.onc.1208644
URIhttp://hdl.handle.net/10261/49845
DOIhttp://dx.doi.org/10.1038/sj.onc.1208644
ISSN0950-9232
E-ISSN1476-5594
Appears in Collections:(CIB) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.